Before You DecideJuly 17, 2026

Before You Decide · July 17, 2026 · 4 min · By Emory Blackwood

GLP-1 Weight-Loss Drugs Before Rhinoplasty: What to Tell Your Surgeon

Ozempic, Wegovy, and Mounjaro have quietly become a pre-surgery safety question. Why these medications matter for anesthesia, and how the timing is usually handled.

Millions of people now take a GLP-1 medication, the class that includes semaglutide (sold as Ozempic and Wegovy) and tirzepatide (sold as Mounjaro and Zepbound), for weight loss or type 2 diabetes. That popularity means a growing share of rhinoplasty patients arrive at the consultation already on one of these drugs, often without realizing it belongs on the same disclosure list as blood thinners and fish oil. It does, and the reason is worth understanding before you book a date.

Why a weight-loss drug matters for nose surgery

GLP-1 medications work in part by slowing gastric emptying, which is how they blunt appetite and keep you feeling full. The catch is that a stomach that empties slowly can still hold food and liquid many hours after your last meal, even when you have followed the usual overnight fasting rules to the letter. Under general anesthesia, that retained stomach content is the exact ingredient behind pulmonary aspiration, when material from the stomach is inhaled into the lungs. Anesthesiologists spend a great deal of effort preventing aspiration, and a drug that keeps the stomach fuller for longer quietly works against that goal. The American Society of Anesthesiologists issued consensus guidance on these medications precisely because case reports began describing full stomachs in patients who had fasted correctly. The drug label information collected by the NIH at MedlinePlus lists delayed gastric emptying among semaglutide's expected effects.

Rhinoplasty adds its own wrinkle

Nose surgery is usually performed under general anesthesia, and the surgeon and anesthesiologist are sharing the same airway you breathe through. Anything that raises the odds of nausea or vomiting is unwelcome here for two separate reasons: aspiration risk during the case, and the strain that retching puts on a freshly reshaped nose afterward. GLP-1 drugs are already known for causing nausea, so stacking that tendency on top of anesthesia's own nausea is a combination most teams would rather avoid. If you want the wider picture of how you will be put under, our overview of rhinoplasty anesthesia options walks through what to expect.

What the current guidance actually says

The advice is still evolving, and not every practice handles it identically, but the common pattern looks like this. For medications dosed once a day, teams often ask patients to hold the dose on the day of surgery. For the weekly injections most weight-loss patients use, many anesthesiologists prefer that the last dose fall about a week before the operation so gastric emptying has time to normalize. Some teams instead keep the drug going and simply treat you as a full-stomach patient, adjusting how they secure the airway. None of this is a fixed rule you should apply on your own; it is a conversation, and the right answer depends on your dose, your reason for taking the drug, and any digestive symptoms you are having.

Do not stop on your own if you take it for diabetes

This is the most important safety point in the article. If your GLP-1 medication is managing type 2 diabetes rather than weight alone, pausing it without a plan can send your blood sugar in the wrong direction before surgery. The decision to hold, continue, or bridge to something else belongs to the prescriber and the surgical team together, not to a patient guessing from a blog. Bring the exact name and dose to your pre-operative visit and let them coordinate. This is the same disclosure discipline covered in medications to avoid before rhinoplasty, where the theme is always the same: tell them everything and let them adjust the plan.

Weight changes can also affect the result itself

There is a second, slower consideration beyond the anesthesia question. Significant ongoing weight loss changes the fat pads and soft tissue of the face, which can subtly shift the balance a surgeon is planning around. It is reasonable for a surgeon to prefer that your weight be relatively stable before finalizing a plan built on facial proportions, so that the nose you agree on in imaging still suits your face a year later. If you are early in a weight-loss journey, that is worth raising openly at the rhinoplasty consultation rather than after the fact.

How to handle it in practice

The playbook is short. Put the medication on your written intake, including the brand name, the dose, and how long you have taken it. Ask directly what the practice wants you to do about the days before surgery, and get the instruction in writing so a busy morning does not scramble it. Follow the fasting instructions you are given exactly, and mention any nausea, bloating, or feeling of fullness in the days beforehand, because those symptoms hint that your stomach is still emptying slowly. Patient guidance from the American Society of Anesthesiologists reinforces the same habit for every medication and supplement you take.

The takeaway is simple. GLP-1 drugs are not a reason you cannot have rhinoplasty, but they are a genuine reason to speak up early. Disclosed and planned for, they are a routine adjustment your team makes all the time. Hidden, they turn a well-understood anesthetic into an avoidable gamble, and that is a trade no good result is worth.